![Medical research / Pharmaceuticals policy / Health care / Health / Clinical research / Clinical pharmacology / Clinical trials / Drug safety / Pharmacovigilance / Adverse drug reaction / Nonsteroidal anti-inflammatory drug / Yellow Card Scheme Medical research / Pharmaceuticals policy / Health care / Health / Clinical research / Clinical pharmacology / Clinical trials / Drug safety / Pharmacovigilance / Adverse drug reaction / Nonsteroidal anti-inflammatory drug / Yellow Card Scheme](https://www.pdfsearch.io/img/5742991fbcd7da0cc84629c2c15e69ee.jpg) Date: 2015-05-26 07:21:00Medical research Pharmaceuticals policy Health care Health Clinical research Clinical pharmacology Clinical trials Drug safety Pharmacovigilance Adverse drug reaction Nonsteroidal anti-inflammatory drug Yellow Card Scheme | | Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., AhmedabadAdd to Reading ListSource URL: www.iimahd.ernet.inDownload Document from Source Website File Size: 551,68 KBShare Document on Facebook
|